Amy Dix Rock

Vice President, Clinical Development & Regulatory Affairs at Altor BioScience Corp.

Amy Dix Rock

Amy Dix Rock

Vice President, Clinical Development & Regulatory Affairs at Altor BioScience Corp.

Biography

Dr. Amy D. Rock is Senior Director-Regulatory & Scientific Affairs at Cumberland Pharmaceuticals, Inc.She received her undergraduate degree from the University of Washington, an MBA from the Vanderbilt Owen Graduate School of Management, and a doctorate degree from the University of Kentucky.

Overview
RelSci Relationships

50

Birthday

1971

Age

47

Relationships
RelSci Relationships are individuals Amy Dix Rock likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at Altor BioScience Corp.

Relationship likelihood: Strong

Consulting Medical Director at Altor BioScience Corp.

Relationship likelihood: Average

Senior Vice President-Research & Development at Altor BioScience Corp.

Relationship likelihood: Average

Former General Manager at Zeneca

Relationship likelihood: Average

Secretary & Senior Vice President-Administrative Services at Cumberland Pharmaceuticals, Inc.

Relationship likelihood: Average

Senior Associate Dean, Clinical Sciences at Vanderbilt University

Relationship likelihood: Average

Vice President, Protein Therapeutics Purification & Development at Altor BioScience Corp.

Relationship likelihood: Average

Founder at Cumberland Pharmaceuticals, Inc.

Relationship likelihood: Average

Senior Vice President, Adult Medical Affairs at Altor BioScience Corp.

Relationship likelihood: Average

Vice President, Manufacturing at Altor BioScience Corp.

Relationship likelihood: Average

Paths to Amy Dix Rock
Potential Connections via
Relationship Science
You
Amy Dix Rock
Vice President, Clinical Development & Regulatory Affairs at Altor BioScience Corp.
Education

The University of Kentucky is a public, land grant university dedicated to improving people's lives through excellence in education, research and creative work, service, and health care. As Kentucky's flagship institution, the University plays a critical leadership role by promoting diversity, inclusion, economic development, and human well-being. The University of Kentucky is guided by its core values: Integrity, Excellence, Mutual respect and human dignity, Diversity and inclusion, Academic freedom, Personal and institutional responsibility and accountability, Shared governance, A sense of community, Work-life sensitivity, Civic engagement and Social responsibility.

The Owen Graduate School of Management is the graduate business school of Vanderbilt University in Nashville, Tennessee, United States. Founded in 1969, Owen awards eight degrees: a standard 2-year Master of Business Administration (MBA), an Executive MBA, an Americas Executive MBA, a Master of Finance, a Master of Accountancy, a Master of Accountancy-Valuation, a Health Care MBA, and a Master of Management in Health Care, as well as a large variety of joint professional and MBA degree programs. Owen is renowned for its Health Care MBA, a unique program that provides students an in-depth educational experience tailored to the health care industry. Owen also offers non-degree programs for undergraduates and executives.

Founded in 1861 by a private gift of 10 acres in what is now the heart of downtown Seattle, the UW is one of the oldest public universities on the West Coast. We’re deeply committed to upholding the responsibility that comes with that legacy. And being public has always meant being accessible. Anyone can enjoy and be enriched by all the UW has to offer, including world-class libraries, art, music, drama, sports and the highest quality medical care in Washington state. Being public also means being engaged with our communities, and through knowledge and discovery we are elevating the quality of lives of others.

Career History
Vice President, Clinical Development & Regulatory Affairs
Current

Altor BioScience Corp. operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer. Its product candidates include ALT-801, a T-cell receptor-targeted immunotherapeutic for cancer and ALT-836, a monoclonal antibody-based tissue factor antagonist treatment of patients with acute respiratory distress syndrome and acute lung injury. The company was founded by Hing C. Wong in 2002 and is headquartered in Miramar, FL.

Vice President, Regulatory & Scientific Affairs
2001 - ?

Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of brands for the hospital acute care, gastroenterology, and oncology. Its product brands include acetadote, caldolor, kristalose, hepatoren, omeclamox, vaprisol, boxaban, vasculan, ethyol, portaban, and totect. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

Other Affiliations

Amy Dix Rock is affiliated with Altor BioScience Corp., Cumberland Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Amy Dix Rock. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Amy Dix Rock's profile does not indicate a business or promotional relationship of any kind between RelSci and Amy Dix Rock.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/amy-dix-rock-3715723
  • https://relationshipscience.com/person/amy-dix-rock-3715723